Medicines associated with folate-homocysteine-methionine pathway disruption.
Enzyme Inhibitors
/ adverse effects
Female
Folic Acid
/ metabolism
Folic Acid Antagonists
/ adverse effects
Folic Acid Deficiency
/ complications
Homocysteine
/ metabolism
Humans
Methionine
/ metabolism
Pregnancy
Tetrahydrofolate Dehydrogenase
/ metabolism
Thymidylate Synthase
/ antagonists & inhibitors
Vitamin B 12 Deficiency
/ etiology
Anti-folates
Folate antagonism
Folate supplementation
Folate–homocysteine–methionine pathway
Toxicity
Journal
Archives of toxicology
ISSN: 1432-0738
Titre abrégé: Arch Toxicol
Pays: Germany
ID NLM: 0417615
Informations de publication
Date de publication:
02 2019
02 2019
Historique:
received:
08
09
2018
accepted:
20
11
2018
pubmed:
1
12
2018
medline:
19
5
2020
entrez:
1
12
2018
Statut:
ppublish
Résumé
Folate is vital for cell development and growth. It is involved in one-carbon transfer reactions essential for the synthesis of purines and pyrimidines. It also acts in conjunction with cobalamin (vitamin B
Identifiants
pubmed: 30499019
doi: 10.1007/s00204-018-2364-z
pii: 10.1007/s00204-018-2364-z
doi:
Substances chimiques
Enzyme Inhibitors
0
Folic Acid Antagonists
0
Homocysteine
0LVT1QZ0BA
Folic Acid
935E97BOY8
Methionine
AE28F7PNPL
Tetrahydrofolate Dehydrogenase
EC 1.5.1.3
Thymidylate Synthase
EC 2.1.1.45
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
227-251Subventions
Organisme : Javna Agencija za Raziskovalno Dejavnost RS
ID : P3-0124
Pays : International